Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Haematologica|August 18, 2025
Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationJaime Sanz, Allain-Thibeault Ferhat, Alexander Kulagin, et al.
Bone Marrow Transplantation|October 7, 2024
An international survey to better understand the current incidence, severity, and management of VOD/SOSMarion Larue, Myriam Labopin, Eolia Brissot, et al.
Bone Marrow Transplantation|November 25, 2025
Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMTJaime Sanz, Allain-Thibeault Ferhat, Anna Maria Raiola, et al.
Cancers|December 30, 2025
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working PartyAgnieszka Tomaszewska, Grzegorz W Basak, Christophe Peczynski, et al.
Journal for Immunotherapy of Cancer|January 10, 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective studyOlaf Penack, Thomas Luft, Christophe Peczynski, et al.
Bone Marrow Transplantation|February 1, 2023
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Gerard Socié, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|July 18, 2022
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical ApplicationEbru Erdoğan, Koray Yalçın, Cansu Hemşinlioğlu, et al.
British Journal of Haematology|March 23, 2023
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remissionArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Bone Marrow Transplantation|April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
Pageof 12